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Background:  Current guidelines recognize the limitation of non-invasive testing to determine the prognosis among patients with implantable 
cardioverter defibrillators (ICD) and preclude the use of an ICD in patients with a life expectancy of less than 1 year. We sought to investigate the 
prognostic impact of the Charlson Co-morbidity Index (CCI) for the prediction of early mortality (EM), death within 1 year, after ICD implantation.
Methods: We identified 1445 patients who underwent ICD implantation at a single center from 1997-2007. Individuals were grouped according 
to the presence of EM (N=110) or death greater than 1 year (N=263). Multivariable Cox proportional analysis was used to calculate the adjusted 
hazard ratios (AHR) of the CCI on the incidence of all-cause mortality.
Results:  Overall the mean age was 65 ± 13 years, LVEF of 28 ± 14% with 58% implanted for primary prevention indications. The median CCI 
(range 1-6) was 3 and 2 for patients with EM and patients with death greater than 1 year respectively. The CCI is an independent predictor of EM 
[AHR 1.24 per single score increase (95% CI 1.07 - 1.42) p=0.004] with an increased probability of EM as the CCI increases (figure). The incidence 
of appropriate shocks for ventricular arrhythmias was significantly lower among those with EM as compared to patients with death greater than 1 
year (10% vs. 35%, p<0.001).
Conclusion: The CCI identifies patients at risk for EM after ICD implantation and may identify patients who may not derive benefit from ICD based 
therapy.
